Published: · Last reviewed:
Best Value GLP-1 for Weight Loss: What's Actually Worth It in 2026
If you've priced GLP-1s lately, you've felt the whiplash. One site says $149. The next says $1,300. A third swears the “cheap” version is basically the same thing. So what's the best value GLP-1 for weight loss — the option that gets you real results without torching your budget or sticking you with a sketchy product?
Short answer — up front
For most people in 2026, the best value is now an FDA-approved medication bought through a direct-pay program — not a compounded copy. The Wegovy pill and Foundayo start at $149/month. Zepbound vials run $299–$449/month and give you the most total weight loss in trials. Compounded semaglutide and tirzepatide can sometimes cost a little less, but the gap has nearly closed — and the rules around compounding are tightening fast.
That's the answer. The rest of this page is the why — including where the “$149” claims hide the real cost, why the cheapest sticker isn't the best value anymore, and exactly which path fits your situation.
Best value for you if…
- Cheapest FDA-approved option → Wegovy pill or Foundayo ($149/mo)
- Most total weight loss + fine with a weekly shot → Zepbound vials ($299–$449/mo)
- Insurance covers a GLP-1 → copay as low as $25/mo (sometimes $0 for Wegovy)
- Want someone to fight your insurance in one place → a concierge telehealth program
Probably not best value for you if…
- You assume compounded is automatically cheapest — in 2026 that's often no longer true
- You're chasing the lowest sticker price at any cost — value = price and legitimacy
- You want an over-the-counter pill or a “research peptide” — this page is about real, prescribed, clinician-supervised treatment
The right GLP-1 provider isn't the same for everyone
It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path, and your budget. A general answer can't resolve those for you.
Find My GLP-1 Path — get your personalized match →free · about 60 seconds
The fastest answer: best-value GLP-1 by your situation
Best value depends on your situation, so start by finding your row. If you want FDA-approved medication, an oral option (Wegovy pill or Foundayo) at $149/month is the cheapest entry, while Zepbound vials ($299–$449/month) deliver the most total weight loss.
| If this is you | Start here | Why it's the best value for you | The watch-out |
|---|---|---|---|
| I want FDA-approved meds + help with insurance | Ro | Brand-name GLP-1s at the lowest cash prices, plus a team that fights for coverage | Membership is separate from medication |
| I want FDA-approved meds + to pick my own doctor | Sesame Care | Broad FDA-approved menu, provider choice, Costco-member pricing | Subscription billed every 28 days, meds separate |
| I already have a prescription | LillyDirect / NovoCare / Costco | Often the cheapest, because you skip the telehealth membership fee | No bundled coaching or insurance help |
| I want the cheapest FDA-approved option | Wegovy pill or Foundayo ($149/mo) | Lowest-cost FDA-approved start; a daily pill, no needles | $149 is the starting dose; higher doses cost more |
| I want the most total weight loss | Zepbound vials ($299-$449/mo) | Up to ~21% body weight in trials at a mid-range price | 45-day refill rule protects the $449 price |
| I'm on a tight budget and open to compounded | The compounded lane (see below) | Can sometimes cost a little less | Not FDA-approved; legal status is narrowing |
| I'm honestly not sure | Find My GLP-1 Path | Answers it for your state, insurance, and budget in ~60 seconds | — |
Your state, your insurance, your budget — about a minute
What is the best value GLP-1 for weight loss right now?
The best value GLP-1 is the lowest total-cost treatment path that still gives you the legitimacy, care, and access you need — not simply the cheapest sticker price. In 2026, that's usually an FDA-approved medication through a direct-pay program, because brand-name prices dropped sharply while compounded prices held roughly flat and lost legal ground.
A year ago, brand-name GLP-1s listed around $1,000–$1,350 a month, so compounded copies at $150–$300 looked like the only sane option for anyone paying cash. Then the manufacturers blinked. Eli Lilly and Novo Nordisk both launched direct-to-patient cash prices that cut the cost of the real, FDA-approved drugs by more than half. Today:
Wegovy pill
starts at
$149/mo
Foundayo
starts at
$149/mo
Zepbound vials
run
$299–$449/mo
Read that again:
The cheapest month-to-month compounded programs commonly advertise around $199/month. An FDA-approved pill ($149) now costs less than a typical month-to-month compounded shot ($199). The discount that justified compounding for years has mostly evaporated.
The honest verdict: for most people, an FDA-approved medication is now both the better value and the more reassuring choice — you get a drug the FDA actually reviewed and approved, made under FDA oversight, for roughly the same money. Compounded still has a place for a specific reader, and we'll show you exactly who. But it's no longer the default smart-money move.
Want to see the real cash price for your dose, and check if insurance covers it?
Check FDA-approved GLP-1 pricing on Ro → (sponsored affiliate link, opens in a new tab)Affiliate link · Ro checks your coverage first, then shows real cash prices
How much do GLP-1s really cost in 2026?
FDA-approved GLP-1s cost far less than their ~$1,000–$1,350 list price if you use a direct-pay program. Prices below are self-pay (no insurance) as of June 2026.
| Option | Type | Treatment path | Lowest self-pay price (June 2026) | Weight loss in trials* | Legal / availability | Best value for |
|---|---|---|---|---|---|---|
| Wegovy pill (oral semaglutide) | FDA-approved | Daily pill | $149/mo (1.5 & 4 mg promo thru Aug 31, 2026); 9 & 25 mg ~$299 | ~14% (continued use ~17%) | FDA-approved; widely available | Cheapest FDA-approved start; pill users |
| Foundayo (orforglipron) | FDA-approved | Daily pill | $149 (0.8 mg) / $199 (2.5 mg) / $299 (5.5 & 9 mg); 14.5 & 17.2 mg are $299 with 45-day refill, else $349 | ~11% (continued use ~12%) | FDA-approved April 1, 2026 | Newest daily pill; take any time of day |
| Wegovy pen (semaglutide 2.4 mg) | FDA-approved | Weekly injection | $349/mo; $199 first 2 fills (thru June 30, 2026); as low as $249/mo on 12-month plan; HD 7.2 mg is $399 | ~15% (2.4 mg); ~21% (HD 7.2 mg) | FDA-approved | Proven injection on a subscription |
| Zepbound vial (tirzepatide) | FDA-approved | Weekly injection (you draw the dose) | $299 (2.5 mg) / $399 (5 mg) / $449 (7.5–15 mg, 45-day refill rule; else $499–$699) | up to ~21% (highest dose) | FDA-approved | Most total weight loss |
| Zepbound KwikPen / pen | FDA-approved | Weekly injection (pen) | $299 first month, $399–$449/mo thereafter | up to ~21% | FDA-approved | Pen convenience near vial price |
| Ozempic (semaglutide) | FDA-approved for type 2 diabetes; off-label for weight | Weekly injection | $349/mo (NovoCare self-pay; $499 for 2 mg) | Diabetes drug; weight loss is off-label | FDA-approved for diabetes | People who want semaglutide as a shot |
| Compounded semaglutide | NOT FDA-approved | Mostly injection | ~$150–$300/mo (varies by provider and plan length) | Not studied as a compounded product — don't assume brand results | Narrowing: shortages resolved; FDA proposed bar on large-scale compounding | Budget-capped readers who accept the uncertainty |
| Compounded tirzepatide | NOT FDA-approved | Mostly injection | ~$200–$350/mo (varies by provider and plan length) | Not studied as a compounded product | Same narrowing as compounded semaglutide | Same as above |
* Weight-loss figures come from clinical trials of the FDA-approved medications only, at the highest or maintenance dose, used with a reduced-calorie diet and more activity. These results do not apply to compounded products, which are not FDA-approved and have not been tested in equivalent trials. Individual results vary significantly.
Want the exact price for your dose — and to find out if insurance will cover it before you pay a cent?
Check your options on Ro → (sponsored affiliate link, opens in a new tab)Affiliate link · Ro's insurance team checks coverage first, then shows your real cash price if not covered
Is compounded semaglutide still worth it for the price?
Compounded semaglutide and tirzepatide are still available through some telehealth pharmacies at around $150–$300/month, but in 2026 they're no longer a clear bargain. The FDA ended the shortages, moved to bar these drugs from large-scale compounding, and warned sellers over misleading claims — and FDA-approved pills now start at the same $149. For most people, the small remaining savings no longer outweigh the legal and supply uncertainty.
What “compounded” means
Compounded drugs are custom-mixed by a pharmacy for an individual patient. They are not FDA-approved, which means the FDA does not review them for safety, effectiveness, or quality before they're sold. We're not allowed to tell you a compounded shot is the “same as” Wegovy or “clinically proven,” because that isn't established — and the FDA has specifically warned companies against saying so.
What changed the value math:
- The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025.
- In spring 2026, the FDA formally proposed keeping semaglutide and tirzepatide off the list that allows large-batch compounding — with a public comment period that closed June 29, 2026. Courts denied legal challenges to stop these changes.
- Large-scale compounding has no clear future. The cheap compounded plan you start today may not be there in six months.
One more risk: fraudulent products
The FDA has warned about fraudulent compounded GLP-1 products reaching U.S. patients — including vials labeled with the names of pharmacies that didn't exist or never made them. That's the real risk of chasing the lowest unverified price.
Is compounded ever still the right call? Yes, for a specific person: you're in a state where a licensed provider can still prescribe it, brand-name is genuinely out of reach even at $149–$449, and you accept the supply and legal uncertainty. If that's you, use the quiz below to get matched to a verified path — don't buy a “GLP-1 pill” ad without knowing exactly what's in it.
Maps your state, your budget, and FDA-approved vs compounded options in about a minute
For raw price-by-channel detail, see our GLP-1 cost without insurance guide.
Which GLP-1 gives the most weight loss per dollar?
Zepbound (tirzepatide) produces the most total weight loss in trials — up to about 21% — at $299–$449/month, making it the best value for people who want maximum results from an injection. The Wegovy pill is the cheapest entry at $149/month with about 14% average trial loss, the best value for people who want a pill or the lowest starting cost.
Most pages stop at price. But “value” is price and results — so we did the math. Here's a fair comparison: take each FDA-approved drug's maintenance-dose self-pay price, divide by its average trial weight loss, and you get a rough “cost per point” of weight lost.
| FDA-approved option | Maintenance price | Avg. trial loss | Approx. cost per point |
|---|---|---|---|
| Wegovy pen (HD 7.2 mg) | $399/mo | ~21% | ≈ $19 |
| Zepbound (15 mg) | $449/mo | ~21% | ≈ $21 |
| Wegovy pill (25 mg) | $299/mo | ~14% | ≈ $21 |
| Wegovy pen (2.4 mg) | $349/mo | ~15% | ≈ $23 |
The honest takeaway:
No option is dramatically better value per pound — they all land around $19 to $23 per point of average trial weight loss. So the per-point math isn't the deciding factor. What matters is what you want: the lowest entry price (the $149 Wegovy pill), the most total weight loss (Zepbound), or a proven middle option (the Wegovy pen).
Read this the right way: those percentages are average trial results, not a promise. Compounded products aren't in the table because they aren't FDA-approved and haven't been studied as products.
Affiliate link · $299–$449/month, no insurance needed
Chasing the fastest drop specifically? Our best GLP-1 for fastest weight loss guide goes deeper on results.
Which FDA-approved GLP-1 is the best value?
Among FDA-approved GLP-1s, the Wegovy pill and Foundayo are the cheapest ($149/month), Zepbound delivers the most total weight loss ($299–$449/month), the Wegovy pen is the proven middle option ($349/month or $249 on a subscription), and Ozempic is a semaglutide injection used off-label for weight.
Wegovy pill — best value for the lowest FDA-approved cost
A daily oral semaglutide at $149/month for the 1.5 mg and 4 mg doses (through Aug 31, 2026), rising to about $299 for the 9 mg and 25 mg doses. Trials showed about 14% average weight loss, and 17% for people who continued treatment. Best if you want a pill and the cheapest start.
Foundayo (orforglipron) — best value for a brand-new daily pill
FDA-approved April 1, 2026, the first daily non-peptide oral GLP-1 — which means, unlike the Wegovy pill, you can take it any time of day, with or without food or water. It's $149/month for the 0.8 mg starting dose, $199 for 2.5 mg, and $299 for the higher doses. Best if you want the newest oral option and flexible timing.
Zepbound — best value for the most total weight loss
Tirzepatide works on two hunger hormones (GLP-1 and GIP), and in trials it produced the most weight loss — up to about 21% at the highest dose. Single-dose vials are $299 (2.5 mg), $399 (5 mg), and $449 for 7.5 mg and up through LillyDirect self-pay. Just mind the 45-day refill rule. Best if results are your priority and you're fine with a weekly shot.
Wegovy pen — best value for a proven injection on a subscription
The most established weight-loss shot at $349/month, dropping to as low as $249/month on a 12-month plan. Best if you want a track record and predictable pricing.
Ozempic — a semaglutide shot, off-label for weight
About $349/month through NovoCare's self-pay program. It's FDA-approved for type 2 diabetes and prescribed off-label for weight loss at a provider's discretion. Best if you specifically want semaglutide as an injection.
Our honest catch
A concierge program like Ro is not the cheapest way to get a GLP-1 if you already have a prescription. If all you want is the lowest medication-only price and you've already got a script, buying direct from LillyDirect or NovoCare (or through Costco) will cost you less, because you skip the membership fee.
But here's why Ro is still the best value for most people who want help: because you pay that membership, you get a team that checks your insurance and fights prior authorization for you, the full FDA-approved menu in one place, your medication at the same cash prices as LillyDirect, NovoCare, and TrumpRx, plus coaching and provider messaging. Ro starts at $39 the first month, then as low as $74/month when you prepay for an annual plan, with medication billed separately. Ro is LegitScript-certified.
Affiliate link · $39 to start, FDA-approved meds at the lowest cash prices
Compare FDA-approved options on Sesame Care → (sponsored affiliate link, opens in a new tab)Affiliate link · or read our full Sesame Care review
Where do GLP-1 prices trick people?
Most GLP-1 price mistakes happen because people compare advertised starter prices instead of total cost. The traps are membership fees stacked on top of medication, dose-based price jumps, refill-timing rules, and “starting at” numbers that only apply to the lowest dose or the first month.
Trap 1: the "starting at $149" headline
That $149 is often the lowest dose or a first-month promo. As your dose goes up, so can the price. Always check the price at the dose you'll actually be on for the long haul, not the teaser.
Trap 2: the membership fee is separate from the medication
Some telehealth programs charge a monthly membership on top of the drug. Example: a $149/month membership + a $149 Wegovy pill = about $298/month, not $149 (closer to $223 if you prepay the membership annually).
Trap 3: dose escalation
You start low and titrate up over weeks. Zepbound starts at 2.5 mg, then steps up. Your starting price is rarely your long-term price.
Trap 4: the refill window
To keep Zepbound's $449 price on the 7.5 mg and higher doses, you have to refill within 45 days of your last delivery; miss the window and the price jumps to $499–$699. Foundayo's two highest doses work the same way.
Trap 5: "HSA/FSA eligible" doesn't always mean they take your card
Sometimes it means you pay first and submit a receipt for reimbursement. Check whether the provider accepts the card at checkout or just gives you paperwork.
"No insurance required" doesn't mean cheap forever
It means you're paying cash. Cash can be a great deal — but only if you've checked the month-3 and month-12 price, not just month one.
28-day billing isn't monthly
A "$99/month" plan billed every 28 days is actually 13 billing cycles a year — which works out to about $1,287 for the subscription alone.
Including any membership fee — before you commit
What's the real 12-month cost?
The real 12-month cost depends on whether you stay on starter pricing, escalate your dose, pay a membership fee, and refill on time. Use this formula:
| Path | Simple 12-month illustration | What could move it |
|---|---|---|
| Wegovy pill (direct / FDA-approved) | ~$149 to start, then dose-based ongoing pricing | Dose, promo end dates, membership if you use one |
| Zepbound vials (direct / FDA-approved) | $299 start, $449 maintenance with on-time refills | Dose, the 45-day refill rule |
| Wegovy pen on a 12-month plan | ~$249/mo × 12 ≈ $2,988 medication | Plan term, dose, insurance |
| Ro (FDA-approved + concierge) | Membership ($39 first, then $74–$149/mo) + medication | Annual vs monthly plan, your dose, coverage |
| Sesame (FDA-approved + provider choice) | Subscription ($59–$99/mo) + medication | Subscription term, Costco pricing, coverage |
| Compounded (cash-pay) | ~$150–$300/mo, varies by provider and plan length | Legal/supply changes, refill price, commitment terms |
Two plans with the same “starting price” can cost wildly different amounts over a year. Always run the 12-month number before you pick.
Find My GLP-1 Path · before you choose
What's the best value GLP-1 if you have insurance or Medicare?
If your insurance covers a GLP-1, that's almost always the best value — your copay can be as low as $25/month (sometimes $0 for Wegovy), cheaper than any cash-pay option, so check coverage first. Starting July 1, 2026, the Medicare GLP-1 Bridge will cover certain FDA-approved GLP-1s for weight management at a $50/month copay for eligible Medicare Part D beneficiaries.
Commercial insurance
Many plans cover GLP-1s for weight (copay as low as $25, sometimes $0 for Wegovy), though prior authorization is common and slow. That's exactly where a concierge program earns its fee — it handles the paperwork for you. Manufacturer savings cards can bring eligible patients to as little as $25 a month. At Sesame, for example, an insured patient on the $59/month annual subscription plus a $25/month medication copay lands around $84/month before any labs or taxes.
Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027)
- Eligible Medicare Part D beneficiaries pay a $50 copay for certain GLP-1s when prescribed for weight management with prior authorization
- Covered: Foundayo, Wegovy (injection and tablets), and the Zepbound KwikPen
- Not included: Zepbound single-dose vials and pens (KwikPen only)
- If prescribed for a use Part D already covers (type 2 diabetes, sleep apnea, cardiovascular risk), you go through Part D, not the Bridge
- Medicare enrollees can still use cash-pay programs like LillyDirect, as long as nothing is billed to their plan
Affiliate link · coverage check is free · team handles prior authorization
On Medicare? See our Medicare GLP-1 Bridge guide, or start with Find My GLP-1 Path.
What's the best value GLP-1 without insurance?
Without insurance, the best value splits into two lanes: FDA-approved cash-pay and compounded cash-pay. FDA-approved oral options (Wegovy pill, Foundayo) now start at $149/month — at or below most compounded prices — with no legal cloud.
Already have a prescription?
Buy direct: NovoCare lists Wegovy from $149/month for lower-dose tablets and about $349/month for many injection doses. Costco members can get Wegovy or Ozempic injections for $349/month and the Wegovy pill for as little as $149/month. You skip the membership fee entirely.
Need a prescription too?
A telehealth program is the move. For FDA-approved meds with support, Ro or Sesame. For the lowest possible cash price open to compounded, the compounded lane — knowing the tradeoffs above.
| Your situation | Best-value move |
|---|---|
| Already have a prescription | Compare LillyDirect / NovoCare / Costco first |
| Need a prescription + want FDA-approved | Ro (insurance help) or Sesame (provider choice) |
| Need the lowest cash price + open to compounded | The compounded lane (read the legal section) |
| Honestly unsure | Find My GLP-1 Path |
Affiliate link · $39 to start · same cash prices as LillyDirect and NovoCare
What's the best value if you want a pill instead of a shot?
If you want an FDA-approved pill, compare the Wegovy pill and Foundayo — both start at $149/month — through Ro, Sesame, or direct programs. For years, GLP-1s meant weekly shots. Not anymore.
Wegovy pill (oral semaglutide)
- $149/month starting dose
- Must be taken on empty stomach; wait 30 min before food
- ~14% average trial weight loss (17% continued use)
- Same active ingredient as Wegovy injection
Foundayo (orforglipron)
- $149/month starting dose
- Any time of day, with or without food or water
- ~11% average trial weight loss (12% continued use)
- Approved April 1, 2026 — brand-new option
Pills tend to produce somewhat less weight loss than the strongest injections, but for many people, “a pill I'll actually take” beats “a shot I dread.” If you're open to compounded needle-free formats (drops, lozenges), keep the line clear: those are compounded, not FDA-approved oral medications, and shouldn't be compared as equivalent to the Wegovy pill or Foundayo.
See our pill vs injection guide for the full comparison.
Affiliate link · both start at $149/month, no needles
How we picked — and what we actually verified
We scored every option on the RX Index Score — five things, in this order: clinical legitimacy (is it a real, licensed, FDA-approved path?), care quality (clinician access, labs, follow-up), transparency (clear pricing, fees separated, honest cancellation terms), access (your state, treatment paths, insurance help, shipping), and cost (first-month, ongoing, 12-month). On a value page, cost matters a lot — but it never outranks clinical legitimacy.
What we actually verified (June 2026) — expand to see
- Zepbound self-pay vial prices ($299 / $399 / $449) and the 45-day refill rule (regular price $499–$699) — Eli Lilly / LillyDirect terms
- Foundayo dose-by-dose pricing ($149 / $199 / $299) and approval date (April 1, 2026) — LillyDirect
- Wegovy self-pay prices (pen $349, intro $199, HD $399; pill $149) and subscription pricing ($249–$329) — NovoCare / Wegovy.com
- Ro ($39 first month, then as low as $74/month annual; meds billed separately at LillyDirect/NovoCare/TrumpRx prices) — ro.co
- Sesame ($59 annual / $99 monthly subscription, medication separate) — SesameCare.com
- Medicare GLP-1 Bridge ($50 copay, July 1, 2026–Dec 31, 2027, eligible Part D beneficiaries) — CMS.gov
- Compounding status (shortages resolved 2025; FDA proposal to bar large-scale compounding; comment period closed June 29, 2026; FDA warnings on fraudulent compounded products) — FDA.gov
We don't use fake reviews, fake star ratings, or a made-up “medically reviewed by” line. We use the FDA and manufacturers for medical and price facts. Availability and exact prices change by provider and state.
Frequently asked questions
What is the best value GLP-1 for weight loss in 2026?
For most people, an FDA-approved option through a direct-pay program. The Wegovy pill and Foundayo are the cheapest at $149/month; Zepbound vials ($299-$449/month) deliver the most total weight loss for injection users. If insurance covers a GLP-1, the copay can be even lower.
Is compounded semaglutide cheaper than Wegovy?
Usually not meaningfully anymore. Compounded semaglutide runs about $150-$300/month, but the FDA-approved Wegovy pill now starts at $149/month, and compounded products are not FDA-approved and face a narrowing legal status after the FDA's 2025-2026 actions.
Which GLP-1 causes the most weight loss?
In trials of the FDA-approved drugs, Zepbound (tirzepatide) produced the most - up to about 21% at the highest dose, with diet and exercise. Compounded products are not studied as products, so brand-name results do not apply. Individual results vary.
How much does a GLP-1 cost per month without insurance?
Through direct-pay programs: Wegovy and Foundayo pills from $149; the Wegovy pen $349 (as low as $249 on a subscription); Zepbound vials $299-$449. List prices without these programs are about $1,086-$1,349.
Is compounded semaglutide still legal in 2026?
It is narrowing. The FDA resolved the shortages in 2025 and moved to bar semaglutide and tirzepatide from large-scale compounding, with a public comment period that closed June 29, 2026. Patient-specific (503A) compounding still exists but is legally precarious when it copies an available drug.
Does Medicare or insurance cover GLP-1s for weight loss?
Many commercial plans cover them (copay as low as $25, sometimes $0 for Wegovy), though prior authorization is common and some plans exclude weight-loss GLP-1s. The Medicare GLP-1 Bridge runs July 1, 2026 through December 31, 2027, covering Foundayo, Wegovy (injection and tablets), and the Zepbound KwikPen at a $50/month copay for eligible Part D beneficiaries.
Pill or injection - which GLP-1 is the better value?
A pill (Wegovy pill or Foundayo, $149/month) is the cheaper entry and suits people who dislike needles. An injection (Zepbound, $299-$449/month) tends to deliver more total weight loss. The best value depends on your priority and how you feel about shots.
Can I use HSA or FSA money for GLP-1 treatment?
Often, yes - GLP-1s prescribed for a medical reason are generally HSA/FSA-eligible. But eligible does not always mean a provider accepts your HSA/FSA card at checkout; some make you pay first and submit a receipt for reimbursement. Check the provider's payment options before signing up, and keep your receipts.
What happens after the starter price ends?
Your dose and the program's terms decide. Many starter prices apply to the lowest dose or the first month or two, then step up - for example, the Wegovy pill moves from $149 toward $299 at higher doses, and the Wegovy pen intro is $199 for the first two fills, then $349. Before committing, look up the price at the maintenance dose you expect to reach.
Which GLP-1 path is cheapest if I already have a prescription?
Buying direct, in most cases - LillyDirect for Zepbound ($299-$449) or NovoCare for Wegovy ($149-$399) - because you skip any telehealth membership fee. Costco members can also get strong self-pay pricing. A concierge program is worth its fee mainly when you need insurance help, not when you just want the cheapest fill.
What should I avoid?
Avoid “research peptides,” unlicensed sellers, sites that hide which pharmacy fills your order, and any provider that claims a compounded GLP-1 is FDA-approved or the same as a brand-name drug. The FDA has warned about fraudulent compounded products, so those claims are red flags.
A quick word on safety
GLP-1s are powerful, prescription-only medications — not supplements. Many FDA-approved GLP-1s carry a boxed warning for a risk of thyroid C-cell tumors based on rodent studies, and they shouldn't be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Common side effects include nausea, vomiting, diarrhea, constipation, and stomach pain; more serious risks include pancreatitis and gallbladder problems. Safety details vary by medication, so always check the prescribing information for the specific drug a clinician recommends. The best value is always one prescribed and supervised by a licensed clinician who knows your history.
Still not sure?
Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz and get a personalized action plan.
Find My GLP-1 Path — get your personalized action plan →Researched and written by the editorial team at The RX Index — independent guidance for choosing your GLP-1 path. Pricing and regulatory status were verified against manufacturer, FDA, and CMS primary sources in June 2026 (see “What we actually verified”). The RX Index is a decision resource, not a medical provider, and this is not medical advice. Talk to a licensed clinician before starting any GLP-1. Last verified: June 2026 · Reviewed monthly; next update due July 2026.
Related guides
The RX Index is an independent editorial publisher. We score GLP-1 providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost. We are not affiliated with Eli Lilly, Novo Nordisk, or any drug manufacturer. We may earn a commission if you visit a provider through our links.